LLY

1,120.29

-0.83%↓

JNJ

235.16

-0.31%↓

ABBV

222.63

+0.73%↑

UNH

408.01

-0.62%↓

MRK

115.09

+0.17%↑

LLY

1,120.29

-0.83%↓

JNJ

235.16

-0.31%↓

ABBV

222.63

+0.73%↑

UNH

408.01

-0.62%↓

MRK

115.09

+0.17%↑

LLY

1,120.29

-0.83%↓

JNJ

235.16

-0.31%↓

ABBV

222.63

+0.73%↑

UNH

408.01

-0.62%↓

MRK

115.09

+0.17%↑

LLY

1,120.29

-0.83%↓

JNJ

235.16

-0.31%↓

ABBV

222.63

+0.73%↑

UNH

408.01

-0.62%↓

MRK

115.09

+0.17%↑

LLY

1,120.29

-0.83%↓

JNJ

235.16

-0.31%↓

ABBV

222.63

+0.73%↑

UNH

408.01

-0.62%↓

MRK

115.09

+0.17%↑

Search

Fate Therapeutics Inc

Open

SectorHealthcare

1.9 -2.56

Overview

Share price change

24h

Current

Min

1.8599999999999999

Max

2.01

Key metrics

By Trading Economics

Income

1.2M

-31M

Sales

-70K

1.3M

EPS

-0.26

Profit margin

-2,402.848

Employees

161

EBITDA

12M

-30M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+137.81% upside

Dividends

By Acuity

Next Earnings

10 sie 2026

Market Stats

By TradingEconomics

Market Cap

-31M

223M

Previous open

4.46

Previous close

1.9

News Sentiment

By Acuity

28%

72%

76 / 342 Ranking in Healthcare

Fate Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

About Fate Therapeutics Inc

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
help-icon Live chat